Business
Variation of Terms of Warrant Instrument
Variation of Terms of Warrant Instrument.
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"\n \nRNS Number : 0020Z Hemogenyx Pharmaceuticals PLC 15 May 2019 \n\nHemogenyx Pharmaceuticals plc\n(\"Hemogenyx\" or the \"Company\")\n \nVariation of Terms of Warrant Instrument\n \nHemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments designed to transform bone marrow transplantation for the treatment of blood diseases, announces that it has come to the Company's attention that it has not been able to issue warrants to all Qualifying Shareholders under the terms of the Warrant Instrument dated 8 September 2017. This may be the case particularly for shares held through nominee companies. As a result, the Company's board of directors has resolved to vary the terms of the Warrant Instrument to impose a new final deadline for the submission of claims for warrants, together with satisfactory supporting evidence, of Friday 14 June 2019. No further extension beyond this deadline will be granted and no claims or evidence will be accepted after expiration of the deadline.\n \nAccording to the terms of the Warrant Instrument shareholders who held shares of the Company from 5 October 2017, being the date of readmission of its shares to trading on the main market of the London Stock Exchange (\"Admission\"), for a period of 60 days (\"Qualifying Shareholders\") were entitled to apply to receive 1 warrant to subscribe in cash at four pence (£0.04) per share for Ordinary Shares in the capital of the Company for every 2 Ordinary Shares held through the qualifying period to 3 December 2017 (the \"Warrant Issue Date\").\n \nQualifying Shareholders with outstanding claims for warrants are invited to submit completed copies of the Warrant Entitlement Certificate form set out as Schedule 4 of the Warrant Instrument along with evidence of their qualifying holdings on or before Admission and on or after the Warrant Issue Date. Qualifying Shareholders with holdings through nominees are encouraged to request their nominees' assistance in providing evidence supporting claims to warrants. The Company's board of directors has resolved to accept warrant claims from nominees on behalf of Qualifying Shareholders so long as evidence for the entitlement of each individual underlying Qualifying Shareholder is demonstrated to the board's satisfaction.\n \nCopies of the Wa...